Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01928160
Title Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Erlotinib + Pemetrexed Disodium

Pemetrexed Disodium

Carboplatin

Carboplatin + Erlotinib

Cisplatin

Cisplatin + Erlotinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.